DNA Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
834
Frequently Asked Questions
What is Market Cap of Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A?
What is the 52-week high for Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A?
What is the 52-week low for Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A?
What is Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A stock price today?
What was Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A?
How many employess does Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A has?